[HTML][HTML] The anomalous magnetic moment of the muon in the Standard Model
…, M Fael, CS Fischer, E Gámiz, Z Gelzer, JR Green… - Physics reports, 2020 - Elsevier
We review the present status of the Standard Model calculation of the anomalous magnetic
moment of the muon. This is performed in a perturbative expansion in the fine-structure …
moment of the muon. This is performed in a perturbative expansion in the fine-structure …
Bisphosphonates: preclinical review
JR Green - The oncologist, 2004 - academic.oup.com
… These findings were confirmed in another independent study using highly sensitive in vivo
imaging of MDA-MB-231 cells genetically engineered to express green fluorescent protein [55…
imaging of MDA-MB-231 cells genetically engineered to express green fluorescent protein [55…
Colletotrichum: a model genus for studies on pathology and fungal–plant interactions
…, HB Hughes, RJ O'Connell, JR Green - Fungal genetics and …, 1999 - Elsevier
… JR Green and RJ O’Connell has been supported by grants and studentships from the
Biotechnology and Biological Sciences Research Council of the United Kingdom. IACR-Long …
Biotechnology and Biological Sciences Research Council of the United Kingdom. IACR-Long …
[BOOK][B] Microeconomic theory
A Mas-Colell, MD Whinston, JR Green - 1995 - hawkinqian.com
Chapter 1 is short and preliminary. It consists of an introduction to the theory of individual
decision making considered in an abstract setting. It introduces the decision maker and her …
decision making considered in an abstract setting. It introduces the decision maker and her …
A comparison of tournaments and contracts
JR Green, NL Stokey - Journal of Political Economy, 1983 - journals.uchicago.edu
Tournaments, reward structures based on rank order, are compared with individual contracts
in a model with one risk-neutral principal and many risk-averse agents. Each agent's output …
in a model with one risk-neutral principal and many risk-averse agents. Each agent's output …
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
…, L Devy, JM Foidart, V Castronovo, JR Green - … of Pharmacology and …, 2002 - ASPET
Bisphosphonate drugs inhibit osteoclastic bone resorption and are widely used to treat
skeletal complications in patients with tumor-induced osteolysis. We now show that zoledronic …
skeletal complications in patients with tumor-induced osteolysis. We now show that zoledronic …
On the division of profit in sequential innovation
JR Green, S Scotchmer - The Rand journal of economics, 1995 - JSTOR
In markets with sequential innovation, inventors of derivative improvements might undermine
the profit of initial innovators through competition. Profit erosion can be mitigated by …
the profit of initial innovators through competition. Profit erosion can be mitigated by …
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts
DJ Paterson, WA Jefferies, JR Green, MR Brandon… - Molecular …, 1987 - Elsevier
Mouse monoclonal antibodies (MAbs) have been prepared against rat T cell blasts. One
MAb called MRC OX-40 recognized an antigen that differed from any previously described in …
MAb called MRC OX-40 recognized an antigen that differed from any previously described in …
Atmospheric mercury deposition during the last 270 years: a glacial ice core record of natural and anthropogenic sources
…, JF Dewild, DD Susong, JR Green… - … science & technology, 2002 - ACS Publications
Mercury (Hg) contamination of aquatic ecosystems and subsequent methylmercury bioaccumulation
are significant environmental problems of global extent. At regional to global scales, …
are significant environmental problems of global extent. At regional to global scales, …
Preclinical pharmacology of CGP 42′ 446, a new, potent, heterocyclic bisphosphonate compound
JR Green, K Müller, KA Jaeggi - Journal of Bone and Mineral …, 2020 - academic.oup.com
We have investigated the pharmacologic effects of a new bisphosphonate compound, CGP
42′446 [2‐(imidazol‐1‐yl)‐1‐hydroxyethylidene‐1,1‐bisphosphonate], on bone metabolism…
42′446 [2‐(imidazol‐1‐yl)‐1‐hydroxyethylidene‐1,1‐bisphosphonate], on bone metabolism…